In your interventional cardiology practice, which markers of risk, in the patient who has undergone a PCI, do you focus on to promote consideration for using a PCSK9 inhibitor?

Name: In your interventional cardiology practice, which markers of risk, in the patient who has undergone a PCI, do you focus on to promote consideration for using a PCSK9 inhibitor?
Uploaded: 2019-03-06T00:00:00+00:00

CLICK HERE FOR CME CREDIT

In your interventional cardiology practice, which markers of risk, in the patient who has undergone a PCI, do you focus on to promote consideration for using a PCSK9 inhibitor?z

Created by

Presenter

Ulf Landmesser MD, FESC

Professor of Cardiology Medical Director, Department of Cardiology Charite University Hospital Berlin, Germany